Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.
Masahito NakanoHironori KogaTatsuya IdeRyoko KuromatsuSatoru HashimotoHiroshi YatsuhashiMasataka SeikeNobito HiguchiMakoto NakamutaSatoshi ShakadoShotaro SakisakaSatoshi MiumaKazuhiko NakaoYoko YoshimaruYutaka SasakiSatoshi OedaYuichiro EguchiYuichi HonmaMasaru HaradaKenji NagataSeiichi MawatariAkio IdoTatsuji MaeshiroShuichi MatsumotoYuko TakamiTetsuo SohdaTakuji TorimuraPublished in: Cancer medicine (2019)
A high AFP level and multiple occurrences of HCC before DAA therapy are associated with a high risk for HCC recurrence after curative treatment. Follow-up after DAA therapy should include special attention to the abovementioned risk factors.